Last news
Elite Robots Launches RoboBarista to Revolutionize Self-Service Coffee Experiences in Commercial and Public Spaces

Elite Robots Launches RoboBarista to Revolutionize Self-Service Coffee Experiences in Commercial and Public Spaces

SHANGHAI, April 30, 2026 /PRNewswire/ -- Elite Robots, a global leader in collaborative robotics, today announced RoboBarista, a fully autonomous coffee station designed for high-traffic commercial spaces. Combining precision cobot technology with...

Driving the Global Food Revolution: Japan's Cutting-Edge Food Processing Technology Takes Center Stage

Driving the Global Food Revolution: Japan's Cutting-Edge Food Processing Technology Takes Center Stage

FOOMA JAPAN 2026 to Showcase Next-Generation Solutions Shaping the Future of Food Processing and Global Quality Standards TOKYO, April 30, 2026 /PRNewswire/ -- The Japan Food Machinery Manufacturers' Association (FOOMA) will host FOOMA JAPAN 2026,...

MetaComp Group Completes Tether Gold (XAUT) Proof-of-Concept and Launches Commercial Tokenised Gold Capabilities for Institutional Clients

MetaComp Group Completes Tether Gold (XAUT) Proof-of-Concept and Launches Commercial Tokenised Gold Capabilities for Institutional Clients

MetaComp Group validates tokenised gold across three use cases — cross-border payments, long-term value preservation, and gold-collateralised working capital — following a live proof-of-concept that successfully executed a US$10,000 equivalent...

D3 Bio Presents KRAS Pipeline Updates at AACR 2026; Elisrasib (D3S-001), a Next-Generation KRAS G12C Inhibitor, Shows Strong Phase 2 Efficacy Across Multiple Tumor Types

D3 Bio Presents KRAS Pipeline Updates at AACR 2026; Elisrasib (D3S-001), a Next-Generation KRAS G12C Inhibitor, Shows Strong Phase 2 Efficacy Across Multiple Tumor Types

Elisrasib monotherapy demonstrates notable efficacy in three major tumor types at its recommended phase 2 dose (RP2D , 600 mg QD). Phase 2 clinical outcomes include: 2L+ KRAS G12Ci–naive NSCLC: ORR of 58.8%, mPFS of 12.2 months 2L+ colorectal cancer...

Traveloka dаta: Southeast Asia Travelers Book 25% More on Double-Digit Dates, Even Without Sales

Traveloka dаta: Southeast Asia Travelers Book 25% More on Double-Digit Dates, Even Without Sales

SINGAPORE, April 30, 2026 /PRNewswire/ -- Traveloka data across five markets reveals that double-digit dates have become a self-organizing travel calendar, with organic booking lifts recorded even when no campaign was running. The platform's biggest...

ILIFE A30 Pro: Smart Cleaning Power That Rivals Premium Models Without the Premium Price

ILIFE A30 Pro: Smart Cleaning Power That Rivals Premium Models Without the Premium Price

SHENZHEN, China, April 30, 2026 /PRNewswire/ -- ILIFE A30 Pro continues to stand out in 2026 as a highly competitive robot vacuum offering flagship-level features at an accessible price. At its current price, it combines laser navigation mapping...

NETMARBLE TO HOST CHARACTER NAME RESERVATION EVENT FOR GAME OF THRONES: KINGSROAD ON MAY 8

NETMARBLE TO HOST CHARACTER NAME RESERVATION EVENT FOR GAME OF THRONES: KINGSROAD ON MAY 8

SEOUL, South Korea, April 30, 2026 /PRNewswire/ -- Netmarble, a leading developer and publisher of high-quality games, announced that it will host a character name reservation event for Game of Thrones: Kingsroad starting May 8 at 05:00 AM(UTC)....

Yunji Technology 2025 Revenue Rises 23% to RMB301 Million, AI Agent Revenue Jumps 194%

Yunji Technology 2025 Revenue Rises 23% to RMB301 Million, AI Agent Revenue Jumps 194%

HONG KONG, April 30, 2026 /PRNewswire/ -- Beijing Yunji Technology Co., Ltd. (2670.HK), the fourth specialty technology company listed under Hong Kong's Chapter 18C rules, today reported its 2025 annual results. Total revenue rose 23.1% year-on-year...

1 ... 7 8 9 10 11 12 13 14 15 ... 4385
menu
menu